IGC To Enter California Market With Hyalolex

IGC to Enter California Market with Hyalolex, its lead cannabis-based supplement for treating and managing Alzheimer’s patients.

MARYLAND: India Globalization Capital (IGC) has designated California as a priority market for Hyalolex, its lead cannabis-based supplement for treating and managing Alzheimer’s patients. “The cannabis market is showing explosive growth and we are aggressively moving forward with our vision of owning and marketing the leading brands for large medical indications such as Alzheimer’s, Parkinson’s, PTSD, Read the full article…